M

MDCX

Medicus Pharma Ltd

0.4470

+0.0270+6.43%
After Hours: 0.4460  -0.0010  -0.22%19:37 04/02 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE0.4100/0.4200
TODAY RANGE0.3912-0.4597
VOL576.43K
MARKET CAP17.59M
52 WEEK RANGE0.3700-8.94
AVG VOL (3M)3.82M
% TURNOVER1.46%
TURNOVER--
P/E (TTM)-0.1634
% RANGE16.31%
EPS(TTM)-2.7356
P/E(FORWARD)-0.4912
P/B-165.5556
BVPS-0.0027
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.98M
SHARES OUTSTANDING39.36M
NEXT EARNINGS05/11-05/26
FREE FLOAT17.84M
LOT SIZE1
EX-DATE10/25/2024
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

MCK

--

生物基因

BIIB

-3.50%
177.34

A

Amgen Inc

AMGN

-1.51%
347.94

S

Shire

SHPG

0.00%
179.20

B

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+34.65%
0.1193

禮來

LLY

-1.98%
935.58

C

Celgene

CELG

0.00%
108.24

TXMD

--

JNJ

--

A

Abbvie Inc

ABBV

-2.86%
208.84

ZTS

--

GILD

--

N

Novo-Nordisk A/S

NVO

+1.37%
36.98

B

Bristol-Myers Squibb Co

BMY

-2.46%
59.60

ALXN

--

PFE

--

賽諾菲

SNY

+0.34%
47.89

S

Sanofi FR

GCVRZ

0.00%
0.8711

N

Novartis

NVS

-0.68%
154.03

如瑞迪博士

RDY

-1.11%
13.32

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.